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Connexins (Cxs), proteins that are vital for intercellular communication in vertebrates, have recently
been shown to play a critical role in lymphatic development. However, our knowledge is currently
limited regarding the functional relationships of Cxs with other proteins and signaling pathways. Cell
culture studies have shown that Cx37 is necessary for coordinated activation of the transcription factor
NFATc1, which cooperates with Foxc2 (another transcription factor) during lymphatic endothelial de-
velopment. These data suggest that Cxs, Foxc2, and NFATc1 are part of a common developmental
pathway. Here, we present a detailed characterization of Foxc2þ /Cx37/ mice, demonstrating that
lymphatic network architecture and valve formation rely on the concurrent embryonic expression and
function of Foxc2 and Cx37. Foxc2þ /Cx37/ mice have lymphedema in utero, exhibit craniofacial
abnormalities, show severe dilation of intestinal lymphatics, display abnormal lacteal development, lack
lymphatic valves, and typically die perinatally (outcomes not seen in Foxc2þ / or Cx37/ mice sepa-
rately). We provide a rigorous, quantitative documentation of lymphatic vascular network changes that
highlight the speciﬁc structural alterations that occur in Foxc2þ /Cx37/ mice. These data provide
further evidence suggesting that Foxc2 and Cx37 are elements in a common molecular pathway directing
lymphangiogenesis.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Lymph vessels in humans form an extensive, hierarchical net-
work that serves the body by executing a number of key functions:
the trafﬁcking of immune cells, absorption of dietary lipids, and
maintenance of extracellular ﬂuid balance. A spectrum of diseases
is directly related to dysfunction of the lymphatic system. Com-
plications with immune cell trafﬁcking are associated with in-
ﬂammatory and autoimmune disease, obstruction of the intestinal
lymph vessels can cause protein-losing enteropathy, and the in-
ability of the lymphatic system to accommodate protein/ﬂuid
loads leads to lymphedema. In addition, the lymphatic vasculature
serves as a route of metastasis for many cancers. Greater emphasis
on understanding lymphatic function has recently arisen due to
the appreciation that a number of pathological states involve the
lymphatic vasculature (Alexander et al., 2010; Wang and Oliver,
2010). Furthermore, various human congenital diseases involve
defects in the architecture of the lymphatic system arising duringKanady),
ail.arizona.edu (M.H. Witte),embryologic development, with deleterious consequences pro-
jecting into early postnatal life and adulthood.
Lymphatic vascular development and function have become
burgeoning ﬁelds of study, and experiments in recent years have
shed light on numerous factors and events that govern the growth,
remodeling, maturation, and function of the lymphatic vasculature
(Koltowska et al., 2013). According to the prevailing model, early
lymphatic development in the mouse begins with the onset of
Prox1 expression in localized clusters of blood endothelial cells
(BECs) within the cardinal vein at embryonic day (E) 9.5, an event
associated with those cells adopting a lymphatic endothelial cell
(LEC) identity. Those LECs then migrate away from the vein to
form the lymph sacs and primary lymphatic plexus. The primary
lymph plexus remodels through further sprouting, branching, and
vessel fusion that establishes a hierarchy of lymph vessels
throughout the tissues of the body. These vessels can be divided
into two broad groups—absorptive vessels (lymph capillaries) and
conducting vessels (pre-collectors, collectors, and lymph trunks).
Much attention has been focused on identifying the molecular
players responsible for orchestrating this developmental course.
Speciﬁc transcription factors (e.g. Sox18, COUP-TFII, Prox1, Foxc2,
NFATc1), cell surface receptors (e.g. Tie2, VEGFR3, neuropilin,
plexin A1, ephrin-B2, β1-integrin) as well as their ligands (e.g.
Fig. 1. Gross images of E18.5 mice. Littermates with the following genotypes are shown: Cx37þ / (A) and (F), Foxc2þ / (B) and (G), Cx37 / (C) and (H), Foxc2þ /Cx37þ /
(D) and (I), and Foxc2þ /Cx37/ (E) and (J). Lateral views of the whole embryo (A)–(E), with corresponding images of the hindlimb (F)–(J). Foxc2þ /Cx37/ embryos
presented with mild generalized edema (E) that also affected the hindlimbs (J). Flattening of the nasal bridge (E, upper arrow) and micrognathism (E, lower arrow) also
occurred. No overt differences in gross embryonic morphology were notable among the other genotypes (A)–(D) and (F)–(I).
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stream effectors are part of the ensemble responsible for
shaping the lymphatic vasculature (for a review, see Koltowska
et al., 2013).
FOXC2, a forkhead box, winged-helix transcription factor ex-
pressed by mesoderm and neural crest derived tissues, is essential
for lymphatic development. Defective lymphatic remodeling, fail-
ure to form lymphatic valves, and abnormal mural cell coverage of
lymphatic vessels have been found in Foxc / mice (Petrova et al.,
2004). Foxc2 / mice also have severe problems with cardiovas-
cular, ocular, and skeletal development and die embryonically/
perinatally (Iida et al., 1997; Winnier et al., 1997). On the other
hand, Foxc2þ / mice are viable, but have lymphatic valve in-
sufﬁciency, distichiasis (double row of eyelashes), and dysmor-
phogenesis of lymph nodes (Kriederman et al., 2003; Shimoda
et al., 2011). As such, these mice have been found to be a relevant
model for lymphedema-distichiasis (LD), an autosomal dominant
disorder in humans that typically presents as distichiasis and the
pubertal onset of lymphedema in the lower limbs (Online Men-
delian Inheritance in Man [OMIM] 153400). Mutations in the
coding region for FOXC2 have been linked to this disorder (Fang
et al., 2000), but some cases of LD have been identiﬁed in non-
coding regions (Sholto-Douglas-Vernon et al., 2005; Witte et al.,
2009).
The current study focuses on the interplay during lymphatic
development between Foxc2 and connexins, a family of proteins
best known for their ability to mediate intercellular communica-
tion by forming channels (termed gap junction channels) that
directly link the cytoplasm of neighboring cells. Connexins can
also form hemichannels (“half” of a gap junction channel)
that allow the passage of substances between the cytoplasm and
extracellular space. Three connexin isoforms (Cx37, Cx43, and
Cx47) have been found in the murine lymphatic vasculature, and
deletions or mutations in these isoforms cause lymphatic defects
in mice and/or humans (Brice et al., 2013; Ferrell et al., 2010;
Kanady et al., 2011). Lymphatic valve (Kanady et al., 2011; Sabine
et al., 2012) and venous valve deﬁciencies (Munger et al., 2013)have been found in Cx37 / mice. Cx43/ mice are neonatal
lethal and have cardiac malformations (Reaume et al., 1995),
but they also lack lymphatic valves at E18.5 (Kanady et al., 2011).
Combining genetic deﬁciencies in both Cx37 and Cx43 results
in chylothorax as evidenced by the phenotype of Cx37 /Cx43þ /
mice, while Cx37 /Cx43 / embryos have lymph-blood mixing
and develop lymphedema in utero (Kanady et al., 2011). In hu-
mans, late-onset lymphedema has been reported in a patient
with oculodentodigital syndrome (ODD; OMIM 164200) – a
disease affecting the face, eyes, teeth, and ﬁngers—which is caused
by mutations in CX43 (Brice et al., 2013). CX47 mutations in
humans have also been linked to lymphedema (Ferrell et al.,
2010).
From the studies above, disruption of lymphatic valve devel-
opment/function was revealed as a commonality between mice
lacking Foxc2, Cx37, or Cx43. Moreover, Cx37 expression in LECs of
developing lymphatics was dramatically reduced in Foxc2/ mice
(Kanady et al., 2011), and siRNA knockdown of Foxc2 in cultured
LECs led to a greater than 50% reduction in Cx37 mRNA levels
(Sabine et al., 2012). These data suggest that Foxc2 regulates (ei-
ther directly or indirectly) Cx37 expression in LECs, although direct
evidence of Foxc2 binding to Cx37 gene regulatory sequences is at
present lacking. In addition, Cx37 is required for coordinated ac-
tivation of NFATc1, a transcription factor that coordinates with
Foxc2 to regulate lymphatic collecting vessel maturation (Sabine
et al., 2012). To further investigate the relationship between Foxc2
and connexins in lymphatic vascular development and function,
we generated mice that have a Foxc2 deﬁciency in conjunction
with a deﬁciency of either Cx37 or Cx43. We hypothesized that if
Foxc2 and Cxs closely participate in a common developmental
pathway, then combining deﬁciencies in these proteins would
recapitulate or worsen the lymphatic abnormalities seen in mice
with deﬁcits in either protein alone. Our ﬁnding of exacerbated
lymphatic defects in Foxc2þ /Cx37 / mice provides further
support for the idea that Foxc2 and Cx37 are part of a common
molecular pathway directing lymphangiogenesis.
Fig. 2. Craniofacial morphometrics of E18.5 embryos. (A)–(D) Superior view of the head of littermates with the following genotypes: WT (A), Foxc2þ / (B),
Foxc2þ /Cx37þ / (C), and Foxc2þ /Cx37/ (D). (E) Schematic diagram of the embryonic head indicating where snout length (green), snout width (blue), and inter-
pupillary distance (magenta) were measured. Bregma and lambda (λ) are shown on the schematic at the anterior and posterior fontanelles, respectively. Double-headed
arrow denotes R (rostral) and C (caudal) directions. (F) Numeric measures of snout length (green points), snout width (blue points), and interpupillary distance (magenta
points) normalized to λ–bregma distance are graphed for WT, Cx37þ / , Foxc2þ / , Foxc2þ /Cx37þ / , and Foxc2þ /Cx37/ mice. The length of the snouts of
Foxc2þ /Cx37/ mice were signiﬁcantly shorter than WT, Cx37þ / , and Foxc2þ /Cx37þ / mice. The width of the snouts of Foxc2þ /Cx37þ / mice were signiﬁcantly
greater than WT and Cx37þ / mice. No statistically signiﬁcant differences were found for interpupillary distance among genotypes analyzed. Scale bar: (A)–(D) 2 mm. Values
are presented as means, with error bars indicating standard error of the mean. Asterisks, po0.05.
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2.1. Mice
Cx37/ (Gja4 /) (Simon et al., 1997), Cx43 / (Gja1 /)
(Reaume et al., 1995), and Foxc2/ (Iida et al., 1997) lines were
maintained on a C57BL/6 background and genotyped by PCR using
previously published methods (Kanady et al., 2011). Cx37þ / ,
Cx43þ / , and Foxc2þ / mice were interbred to generate mice
deﬁcient in both Cx37 and Foxc2 or Cx43 and Foxc2. Animal pro-
tocols were approved by the IACUC Committee at the University of
Arizona (Tucson, AZ).
2.2. Antibodies
Primary antibodies used for immunostaining were as follows:
rabbit antibodies to Cx37 (Simon et al., 2006), Cx43 (C6219, Sig-
ma), Prox1 (11-002, AngioBio; ab11941, Abcam), pHH3 (06-570,
Millipore); rat antibodies to CD31 (550274, BD Biosciences); goat
antibodies to Foxc2 (ab5060, Abcam), Vefgr3 (AF743, R&D Sys-
tems). AfﬁniPure minimal cross reactivity secondary antibodies
(conjugated to Alexa 488, Cy3, Cy5, or Dylight 649) were from
Jackson Immunoresearch.
2.3. Section immunostaining
Tissues were frozen unﬁxed in Tissue-tek O.C.T. and sectioned
at 10 μm. Sections were ﬁxed in acetone at –20 °C for 10 min,
blocked in a solution containing PBS, 4% ﬁsh skin gelatin, 1%
donkey serum, 0.25% Triton X-100, and incubated with primary
antibodies for 1.5 to 3 h at room temperature or overnight at 4 °C.
Sections were washed with PBS containing 0.25% Triton X-100 andthen incubated with secondary antibodies for 30–45 min. After
washing, sections were mounted in Mowiol 40-88 (Aldrich) con-
taining 1,4-diazobicyclo-(2,2,2)-octane and viewed with an
Olympus BX51 ﬂuorescence microscope ﬁtted with a Photometrics
CoolSnap ES2 camera.
2.4. Whole-mount immunostaining
Intestines (with mesentery attached) were ﬁxed in 1% paraf-
ormaldehyde overnight at 4 °C, washed in PBS, permeabilized with
PBS containing 0.3% Triton X-100 overnight, and then blocked
overnight in solution containing PBS, 4% ﬁsh skin gelatin, 1%
donkey serum, 0.25% Triton X-100. Primary antibodies diluted in
PBS containing 0.3% Triton X-100 were applied to the tissue
overnight at 4 °C. After washing, ﬂuorescently labeled secondary
antibodies were incubated overnight at 4 °C. Following ﬁnal wa-
shes, the mesenteries were mounted on slides in Citiﬂuor moun-
tant (Electron Microscopy Sciences). Skin tissue was treated si-
milarly. Whole-mount samples were viewed with an Olympus
BX51 ﬂuorescence microscope ﬁtted with a Photometrics Cool-
Snap ES2 camera or viewed with a Zeiss LSM 510 confocal
microscope.
2.5. Lymphangiography with Evans blue dye
Mice were anesthetized with an intraperitoneal injection of
sodium pentobarbital or ketamine/xylazine mixture and kept
warm. Evans blue dye (EBD) (1% w/v) was injected intradermally
into the hindpaws and a dissecting microscope was used to ex-
amine EBD transport. Evidence of abnormal dye reﬂux into hin-
dlimb skin or mesenteric lymph nodes was noted if present. The
thoracic cavity was then opened and the presence of EBD in the TD
Fig. 3. Lymph-blood mixing in the lymphatics of the skin (C)–(E), intestines (G) and (H), and heart (J) and (K) of Foxc2þ /Cx37 / mice at E18.5. (A) Evans blue dye (EBD)
injection of E18.5 WT embryo showing normal drainage pattern from the inguinal lymph node (arrow) and thoracoepigastric lymphatic vessels. (B) Thoracoepigastric lymph
vessels, higher magniﬁcation view of the white box from (A); note the ﬁne caliber of WT lymph vessels in this region. (C) Blood within the inguinal lymph node (lower box,
arrow denotes same anatomical region as lymph node in panel A) and thoracoepigastric lymph vessels (upper box) of a Foxc2þ /Cx37/ embryo. (D) Higher magniﬁcation
view of lymph node from (C). (E) Higher magniﬁcation view of thoracoepigastric lymph vessels from (C); blood-ﬁlled lymph vessels are digitally outlined in white for better
contrast. (F) Gross image of the small intestine from an E18.5 Cx37þ / control embryo, compared to a Foxc2þ /Cx37 / littermate (G). (H) Higher magniﬁcation view of
white box from (G); blood is present within the serosal lymphatics in the proximal small intestine. (I) Gross image of the heart from E18.5 Cx37þ / control embryo; right/left
auricles and apex are labeled. (J) Blood accumulation in blind-ended vessels of the pericardium in an E18.5 Foxc2þ /Cx37 / embryo. (K) Higher magniﬁcation view of
white box from (J), arrows highlight blood-ﬁlled lymph vessels. St, stomach.
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tercostal lymphatic vessels. EBD was also injected into the ear to
examine EBD transport in the dermal lymph network.
2.6. Quantiﬁcation of lymphatic vascular networks
Maximum intensity projections were generated from confocal
z-stacks of whole-mount immunostained intestine and skin sam-
ples. Regions of intestine or skin that contained blood in the
lymphatics were not included in the analysis as these could have
been dilated due to luminal volume expansion. Manual image
segmentation of the lymphatic vessels was then carried out based
on Prox1 and CD31 or Vegfr3 immunolabeling using Adobe Pho-
toshop CS4. The resulting segmentation was compared against the
individual confocal slices used to create the maximum intensity
projection to ensure accuracy. ImageJ was used to further process
segmented images, and a skeletonization of the lymphatic net-
work was created using the Skeletonize (2D/3D) plugin and
measured using the AnalyzeSkeleton plugin (Arganda-Carreraset al., 2010). Segmented images were loaded into AngioTool (Zu-
daire et al., 2011) for calculation of lacunarity (determined through
box counting). Further details are provided as a supplement (Fig.
S1). Lacteal length was measured from confocal z-stacks using
ImageJ and the Simple Neurite Tracer plugin (Longair et al., 2011).
Lacteal density was calculated by counting the number of lacteals
in X–Z projections and dividing by the area of the ﬁeld.2.7. Statistical analysis
At least three embryos per genotype were analyzed for all
comparisons. Student’s t-test (two-tailed, unequal variance) was
performed for results in Fig. 8I. For Figs. 2F, 5I–L, 6I–J, and 9P–U,
single factor ANOVA was performed for multi-wise comparisons
with post hoc Tukey-Kramer tests when ANOVA yielded a sig-
niﬁcant result. Values were considered statistically signiﬁcant
when po0.05.
Fig. 4. Cx37 is expressed in the submucosal lymphatics of the small intestine and colon. Cryosections of the small intestine (A)–(F) and colon (G)–(L) of E18.5 WT mice are
shown. Vegfr3 immunostaining was used to identify submucosal lymphatic vessels. (A) Vegfr3 and (B) Cx37 immunolabeling of the submucosal lymphatics of the small
intestine. (C) Vegfr3 (magenta) and Cx37 (green) signals colocalize in the submucosal lymphatics and lacteal. (D)–(F) Higher magniﬁcation view of the area denoted by the
arrow in (C), arrowhead in (E) indicates relevant area of Cx37 expression within the lacteal. Vegfr3 (G) and Cx37 (H) immunolabeling of the submucosal lymphatics of the
colon. (I) Vegfr3 (magenta) and Cx37 (green) signals colocalize in the submucosal lymphatics. (J)–(L) Higher magniﬁcation view of the area denoted by the arrow in (I). The
bright, saturated Cx37 signal in (E) is from the arterial submucosal vasculature, also in the lower part of panel (H). Scale bars: (A)–(C, (G)–(I) 50 mm; (D)–(F), (J)–(L) 25 mm.
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3.1. Foxc2þ /Cx37 / mice exhibit generalized edema, craniofacial
abnormalities, and die perinatally
We surveyed mouse embryos at embryonic day (E) 18.5 for
gross phenotypic differences among the following genotypes:
Cx37þ / , Cx37/ , Foxc2þ / , Foxc2þ /Cx37þ / , and
Foxc2þ /Cx37/ . Foxc2þ /Cx37þ / embryos were similar in
appearance to wild type (WT), Cx37þ / , Cx37 / , and Foxc2þ /
embryos (Fig. 1A–D). Conversely, Foxc2þ /Cx37 / embryos had
an overall swollen appearance (indicative of generalized edema),
with the extremities of these animals also affected (Fig. 1E and J).
Blunting of the snout was also noted as a common feature in
Foxc2þ /Cx37/ mice. Thus, while Foxc2þ /Cx37þ / embryos
were overtly normal, lymphedema only became apparent when
there was Foxc2 haploinsufﬁciency in conjunction with the com-
plete loss of Cx37.
Dysmorphic facial features and defects in skeletogenesis have
been reported in Foxc2/ mice, but Foxc2 þ /- mice have been
described as overtly normal in these respects (Iida et al., 1997;
Winnier et al., 1997). Given our initial observations that
Foxc2þ /Cx37/ embryos had blunted snouts, we performed
morphometric analysis of the head in order to further characterize
any craniofacial differences. Length of the snout, snout width, andinterpupillary distance were measured and expressed as a ratio of
the distance between lambda and bregma (points at the posterior
and anterior fontanelles, respectively) in E18.5 mice (Fig. 2A–F).
The snout length of Foxc2þ /Cx37 / (0.85070.005) embryos
was 7% shorter than WT (0.91070.014), 8% shorter than Cx377
(0.92170.006), and 11% shorter than Foxc2þ /Cx37þ / (0.9507
0.016) embryos. The snout of Foxc2þ /Cx37þ / (1.03470.018)
mice was 7% wider than WT (0.96470.014) and 7% wider than
Cx37þ / (0.96570.006) embryos. There were no statistically sig-
niﬁcant changes in interpupillary distance. While craniofacial ab-
normalities have been associated with human cases of lymphe-
dema-distichiasis, we were unable to ﬁnd differences in Foxc2þ /
mice compared to other genotypes using the parameters mea-
sured. Interestingly, craniofacial differences only manifested when
Foxc2 hemizygosity was combined with the loss of one or both
alleles of Cx37 in the mice we surveyed.
Aggregations of blood were faintly visible through the skin of
Foxc2þ /Cx37 / mice at E18.5. Dissections of the embryos re-
vealed that the inguinal lymph node, as well as the dermal lym-
phatic vessels surrounding it, contained blood (Fig. 3A–E, S2).
Within the mesentery and intestinal wall of the proximal small
intestine, there was a network of blood-containing, dilated vessels
in some embryos (Fig. 3F–H). Immunohistochemistry conﬁrmed
the lymphatic identity of these vessels. The degree and extent to
which blood was observed in the lymphatic vessels of the skin and
Fig. 5. Characterization of intestinal lymphatics in WT, Foxc2þ / , Cx37/ , and Foxc2þ /Cx37/ mice at E18.5. Confocal immunomicrographs of the small intestine and
colon from E18.5 WT (A) and (B), Foxc2þ / (C) and (D), Cx37/ (E) and (F), and Foxc2þ /Cx37/ mice are shown; samples were probed for Vegfr3. The lymphatic vessels
were segmented based on Vegfr3 signal and skeletonized. (I)–(L) Quantitation of the submucosal lymphatic network of the proximal small intestine. Submucosal lymph
vessel diameter (I) and submucosal lymph vessel area density (I) of Foxc2þ /Cx37 / mice were signiﬁcantly greater than WT, Foxc2þ / , and Cx37/ mice. Submucosal
lymph vessel length density (K) and submucosal lymphatic branch point density (L) of Foxc2þ /Cx37/ mice were signiﬁcantly lower than WT, Foxc2þ / , and Cx37/
mice. Additionally, submucosal lymph vessel area density of Cx37 / mice was signiﬁcantly greater than WT and Foxc2þ / mice. Scale bar: (A)–(H) 200 mm. Values are
presented as means, with error bars indicating standard error of the mean. Asterisks, po0.05.
J.D. Kanady et al. / Developmental Biology 405 (2015) 33–4638intestine varied from mild to severe. Since Foxc2 / mice have
been reported to have defects in the formation and patterning of
the aortic arch (Iida et al., 1997; Winnier et al., 1997), we also
inspected the heart, aorta, and its distributary blood vessels in
these animals. There were no discernible abnormalities in the
aorta or the principal arterial branches arising from it compared
to other genotypes. However, wide, blind-ended, blood-ﬁlledvessels were present on the surface of the heart, and were
likely dilated pericardial lymphatic vessels (Fig. 3I–K). Thus, in
Foxc2þ /Cx37 / mice, lymph-blood mixing occurred in the skin,
intestine, and pericardial lymphatics, and these mice showed signs
of intestinal and pericardial lymphangiectasia at E18.5.
Foxc2þ /Cx37 / mice collected at E13.5, E18.5 and postnatal
day (P) 0 showed similar developmental progression compared to
J.D. Kanady et al. / Developmental Biology 405 (2015) 33–46 39littermates. Most embryos collected at E18.5 and P0 attempted to
breathe and responded to physical stimuli. However, only two
animals of this genotype survived past weaning age—one died
at two months and one at seven months of age. While
Foxc2þ /Cx37/ mice were fully developed in general by birth,
most died either perinatally or before weaning age.
3.2. Cx37 is expressed in the lacteals and submucosal lymph vessels
of E18.5 mice
Lacteals are specialized lymphatic capillaries found in the villi
of the small intestine that are responsible for a large portion of
dietary fat and lipid-soluble vitamin absorption. In a previous
survey of Cx37 expression, we failed to detect Cx37 expression
in lacteals (Kanady et al., 2011). However, given the defects
in the formation of the intestinal lymphatic vasculature in
Foxc2þ /Cx37/ mice, we looked more closely for Cx37 im-
munostaining in the lymphatic vessels serving the intestines of
E18.5 WT mice. Antibodies against vascular endothelial growth
factor receptor 3 (Vegfr3) were used to identify LECs. Vegfr3 is
expressed by both blood and lymphatic endothelial cells during
early embryogenesis, but becomes primarily restricted to LECs
later in development, where its activation is required for lym-
phangiogenesis (Kaipainen et al., 1995; Karkkainen et al., 2004).
Punctate Cx37 staining was detected in the lacteals (weakly) and
submucosal lymphatics of both the small (Fig. 4A–F) and large
intestine (Fig. 4G–L).
3.3. Foxc2þ /Cx37 / mice have dilated submucosal lymph vessels
in the small intestine and defects in mesenteric lymph vessel re-
modeling and maturation
We performed whole-mount immunoﬂuorescence staining of
E18.5 intestines using antibodies against Vegfr3 to visualize the
intact intestinal lymphatic vasculature (Fig. 5A–H). Confocal mi-
croscopy was used to optically section through the intestinal wall
and evaluate the submucosal lymphatic network and lacteals. By
E18.5, the submucosal lymphatic network in WT mice has formed
a highly branched system of vessels mostly homogenous in dia-
meter (Fig. 5A). In comparison, Foxc2þ /Cx37/ samples had a
striking derangement of the submucosal lymphatic vasculature,
which formed a disorganized network of dilated, cavernous lymph
vessels (Fig. 5G). These vessels were erratic in caliber, ranging from
approximately 20 to over 250 μm in diameter. This variation in
vessel caliber gave the network a mesh-like appearance with holes
that differed greatly in size. The mean submucosal lymph vessel
diameter of Foxc2þ /Cx37 / (45.076.63 mm) mice was 158%
greater than WT (17.571.15 mm) mice, 145% greater than
Foxc2þ / (18.3670.65 mm), and 125% greater than Cx37 /
(19.9671.33 mm) mice (Fig. 5I). The submucosal lymphatic vas-
cular area density (lymph vessel area/tissue area) was 69% greater
in Foxc2þ /Cx37/ (0.84070.022) mice compared to WT
(0.49670.013) mice, 65% greater compared to Foxc2þ /
(0.50970.012) mice, and 43% greater compared to Cx37 /
(0.59370.024) mice (Fig. 5J). Conversely, lymphatic vascular
length density (vessel length/tissue area) in Foxc2þ /Cx37 /
(0.01970.0026) mice was 35% less than WT (0.02970.0014)
mice, 32% less than Foxc2þ / (0.02870.0003) mice, and 37% less
than Cx37 / (0.03070.0011) mice (Fig. 5K). Additionally, there
was a 57% decrease in branch point density (branch points/tissue
area) in the submucosal lymphatics of Foxc2þ /Cx37 / (173745
branch points/mm2) mice compared to WT (402738 branch
points/mm2) mice, a 55% decrease compared to Foxc2þ /
(383719 branch points/mm2) mice, and a 58% decrease compared
to Cx37 / (413731 branch points/mm2) mice (Fig. 5L). Regions
of the proximal small intestine were the most affected, with distalsegments of the small intestine and large intestine showing less
morphological irregularity. We calculated the percentage of tissue
that was within a particular distance of a lymphatic vessel, and the
majority of the parenchyma in the small intestine was closer to a
given vessel in Foxc2þ /Cx37/ mice compared to WT, Foxc2þ / ,
and Cx37 / mice (Fig. S3). Overall, the distribution and pattern-
ing of the submucosal lymphatic vasculature in Foxc2þ /Cx37 /
mice was signiﬁcantly altered, which likely translated to postnatal
lymphatic functional deﬁcits in the intestine.
Localized regions of intense Vegfr3 immunostaining readily
identiﬁed the locations of developing lacteals in E18.5 whole-
mount stained intestines (Fig. 6A–H), which allowed us to quantify
the lacteal density (lacteals/tissue area) as well as measure their
length. We saw lacteals associated with nearly all the villi we ex-
amined, and the lacteal density for WT (107710 lacteals/mm2),
Foxc2þ / (101713 lacteals/mm2), Cx37 / (10877
lacteals/mm2), and Foxc2þ /Cx37 / (8773 lacteals/mm2) mice
were similar (Fig. 6I). However, the lacteals of Foxc2þ /Cx37 /
samples were often wider at the base and 38% shorter
(101.8713.1 mm) compared to WT (165.1712.0 mm), 40% shorter
compared to Foxc2þ / (169.072.6 mm), and 38% shorter com-
pared to Cx37 / (163.3716.8 mm) samples (Fig. 6J).
We evaluated the mesenteric lymphatics across different gen-
otypes at E18.5 (Fig. 7A–H) and P0 (Fig. 7I–P). By E18.5 in WT mice,
the mesenteric lymph vasculature has formed a ﬁne, valved net-
work of vessels with even caliber (Fig. 7A and E). In contrast, most
of the mesenteric lymph vessels of Foxc2þ /Cx37/ mice were
hyperplastic (Fig. 7D and H). Some of the enlarged vessels were
relatively even in caliber, while others were cavernous with highly
irregular caliber. These cavernous segments had a “string of beads”
appearance in some instances. The mesenteric lymphatics also
showed regional variability in the severity of enlargement, with
vessels of relatively normal caliber in some lymphatics primarily
near the intestinal–mesenteric border. The lymphatic develop-
mental anomalies of Foxc2þ /Cx37/ mice within the mesenteric
lymphatics are therefore similar to those seen in the submucosal
lymphatics of the intestine, namely a gross enlargement of vessels
and the formation of an erratic, plexiform vasculature.
Normally, intraluminal valves begin to form in the mesenteric
lymphatic collecting vessels around E15.5 and by E18.5 they are
abundant (Kim et al., 2007). The mesenteric lymph vessels in
Foxc2þ /Cx37 / mice at E18.5 (Fig. 7D and H) and P0 (Fig. 7L and
P) completely lacked valves, and we did not see localized Prox1
upregulation that typically demarcates valve-forming areas. Unlike
the regional variability in overall lymphatic vessel architecture, the
absence of valves was uniformly observed in these animals. In
contrast, mesenteric valves were still present in Foxc2þ / mice at
E18.5, and their relative abundance appeared similar to WT.
However, evidence for apparently incompetent lymphatic valves
has been documented in Foxc2þ / mice, using the Evans blue dye
(EBD) assay (Kriederman et al., 2003). Developing mesenteric
valves were also noted in Cx37 / mesentery at E18.5; a reduction
in the number of these valves has been previously documented for
Cx37 / mice (Kanady et al., 2011; Sabine et al., 2012). Our results
demonstrate that mesenteric lymphatic valve development fails to
initiate or is arrested in the earliest stages when mice have deﬁ-
ciencies in both Foxc2 and Cx37.3.4. Loss of Cx37 increases the mitotic activity of LECs in the me-
sentery of E18.5 mice
We previously reported that Cx37 / embryos develop en-
larged jugular lymph sacs at E13.5 (Kanady et al., 2011). Given the
severe enlargement of lymphatics in Foxc2þ /Cx37 / mice, we
investigated LEC proliferation in the mesenteric lymph vessels
Fig. 6. Lacteal development is disrupted in Foxc2þ /Cx37/ mice at E18.5. Vegfr3 whole-mount immunostaining (imaged via confocal microscopy) highlights the sub-
mucosal lymphatics and lacteals of the proximal small intestine in WT (A)–(C), Foxc2þ / (D)–(F), Cx37/ (G)–(I) and Foxc2þ /Cx37 / (J)–(L) mice. Single longitudinal
sections (optical) fromWT (A), Foxc2þ / (D), Cx37 / (G), and Foxc2þ /Cx37/ (J) mice. Maximum intensity projections of confocal z-stacks in the X–Y and X–Z planes for
WT (B) and (C), Foxc2þ / (E) and (F), Cx37/ (H,I), and Foxc2þ /Cx37 / (K,L) mice. In X–Y projections (B), (E), (H), and (K), lacteals are seen as intense regions of Vegfr3
signal. In X–Z projections (C), (F), and (I), and (L), individual lacteals resemble ropes hanging from the top of each image. Intestinal lumen is directed towards the bottom of
the image in (A), (C), (D), (F), (G), (I), (J), and (L). Measurements of lacteal density (M) and lacteal length (N) for WT (black bars), Foxc2þ / (dark grey bars), Cx37/ (light
grey bars), and Foxc2þ /Cx37/ (white bars) mice are shown. Lacteals from Foxc2þ /Cx37 / mice were signiﬁcantly shorter than WT, Foxc2þ / , and Cx37 / mice.
Scale bar: (A)–(L) 200 mm. Values are presented as means, with error bars indicating standard error of the mean. Asterisks, po0.05.
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phorylated nearly exclusively during M-phase, and has thus been
characterized as a “true” mitotic marker (Hendzel et al., 1997; Li
et al., 2005; Tapia et al., 2006). Whole-mount immunostaining of
E18.5 mesenteries with antibodies directed against phosphory-
lated Histone H3 (pHH3) revealed that the percentage of
mitotically active LECs from Cx37/ mice was 61% higher
(20.0070.53%) compared to WT mice (12.4670.23%) (Fig. 8A–I).Thus, the loss of Cx37 results in increased growth of lymphatic
vessels by affecting mitotic activity.
3.5. The dermal lymphatics of Foxc2þ /Cx37 / mice have abnor-
mal patterning, lack lymphatic valves, and form lymphangiomas
Whole-mount preparations of skin from E18.5 WT, Foxc2þ / ,
Cx37/ , and Foxc2þ /Cx37 / mice were immunostained for Prox1
Fig. 7. Mesenteric lymph vessels of Foxc2þ /Cx37/ mice lack valves and are dilated at E18.5. Prox1 whole-mount immunostaining highlights lymphatic vessels of the
mesentery in WT (A), Foxc2þ / (B), Cx37/ (C), and Foxc2þ /Cx37/ (D) mice at E18.5. Corresponding Prox1 (green) and CD31 (magenta) color composites are shown for
WT (E), Foxc2þ / (F), Cx37/ (G), and Foxc2þ /Cx37/ (H) mesenteries at E18.5. (I)–(L) Prox1 whole-mount immunostaining at P0 for WT (I), Foxc2þ / (J), Cx37 / (K),
and Foxc2þ /Cx37/ (L) mesenteries. (M)–(P) Prox1 (green) and CD31 (magenta) color composites are shown for WT (M), Foxc2þ / (N), Cx37 / (O), and
Foxc2þ /Cx37/ (P) mesenteries at P0. Arrows denote lymphatic valve forming areas; note that none are present in Foxc2þ /Cx37 / mice. Scale bar: (A)–(P) 200 mm.
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PECAM-1) in order to assess lymphatic development (Fig. 9A–O) and
quantify vascular parameters (Fig. 9P–U). The lymphatic network of
the skin in Foxc2þ /Cx37 / embryos was composed of ﬁne vessels,
smaller in caliber than WT, Foxc2þ / , and Cx37/ samples, which
was a stark contrast to the severe enlargement of the lymphatic ves-
sels of the intestinal and mesenteric lymph vessels. However, lym-
phatic vessels in some regions of the skin in Foxc2þ /Cx37/ mice
were hyperplastic. The mean diameter of dermal lymph vessels was
39% smaller in Foxc2þ /Cx37/mice (16.670.1 mm) compared to
WT (27.272.0 mm) mice, and Foxc2þ / (18.271.3 mm) mice had
a mean lymph vessel diameter that was 33% smaller compared to
WT mice (Fig. 9P). The dermal lymphatic vascular fraction in
Foxc2þ /Cx37 / (0.11970.000) mice was 35% less than WT
(0.18470.012) and 27% less than Cx37 / (0.16470.019) mice
(Fig. 9Q). Lacunarity (which evaluates vascular structural non-
uniformity), was signiﬁcantly higher in Foxc2þ /Cx37/
(0.6070.03) samples compared to WT (0.4170.04), indicating that
dermal lymph vessels in Foxc2þ /Cx37 / mice have less homo-
geneous lymphatic coverage in the skin. We also measured tortuosity
of lymph vessel segments, branch point density, and lymph vessel
length density, but found no differences in these measures between
genotypes. Together, these data demonstrate that the dermal lymph
vessels in Foxc2þ /Cx37/ mice were thinner overall (contributing
to a lower lymph vascular area density) and had an uneven distribu-
tion throughout the skin.Lymphatic valves were completely absent from both the ventral
and dorsal skin of Foxc2þ /Cx37/ samples, and localized re-
gions of Prox1 upregulation were not evident in these animals
(Fig. 9J–L). There were also fewer lymphatic valves in the skin
of Foxc2þ / (4.270.4 valves/mm2) and Cx37 / (3.570.2
valves/mm2) mice compared to WT (7.5 þ /- 0.6 valves/mm2)
mice (Fig. 9T). Interestingly, there was regionally skewed reduction
in valves/valve-forming regions in Cx37/ mice, with sig-
niﬁcantly decreased valve density in the dorsal skin (2.070.1
valves/mm2) compared to the ventral skin (5.170.5 valves/mm2).
Thus, similar to mesenteric lymph vessels, there was valve agen-
esis in the dermal lymphatic network of Foxc2þ /Cx37/ mice at
E18.5.
Curiously, despite the reduction in overall dermal lymphatic
vessel caliber and vascular fraction in Foxc2þ /Cx37/ mice at
E18.5, we found that the ends of some lymphatic capillaries had
grown extremely large (to approximately 200–500 μm in dia-
meter). The growths were Prox1 positive, variable in size, and
highly cellular (Fig. 9M). We found them in various locations
within the skin—both ventral and dorsal. CD31 staining tended to
be stronger in these structures compared to surrounding lym-
phatic vessels (Fig. 9N). These results show that hemizygous loss
of Foxc2 combined with the loss of both alleles of Cx37 in mice
promotes the formation of structures that resemble cystic
lymphangiomas.
Fig. 8. Mesenteric lymphatic endothelial cells (LECs) of Cx37/ mice are more
mitotically active than WT mice. Foxc2 (A) and phospho-Histone H3 (pHH3, B)
immunolabeling of WT mesenteric lymphatic vessels. (C) Colocalization of Foxc2
(green) and pHH3 (magenta) signal highlight LECs that are in M-phase of the cell
cycle. (D) Segmentation of mitotic LECs (Foxc2þ/pHH3þ cells) in (C). Foxc2 (E) and
pHH3 (F) immunolabeling of Cx37 / mesenteric lymphatic vessels. (G) A greater
number of mesenteric LECs show colocalization of Foxc2 (green) and pHH3 (ma-
genta) signal in Cx37/ mice. (H) Segmentation of mitotic LECs (Foxc2þ/pHH3þ
cells) in (G). (I) LEC mitotic index measured as the number of Foxc2þpHH3þ cells
divided by total number of Foxc2þ cells; there is a signiﬁcant increase in the
percentage of mitotic mesenteric LECs in Cx37/ mice compared to WT. Note that
there is non-speciﬁc labeling of the cytoplasm of macrophages and mast cells with
the pHH3 antibody, seen as the saturated signal from cells in white (B) and (F) and
magenta (C) and (G). Scale bars: (A)–(C, (E)–(G) 100 mm. Values are presented as
means, with error bars indicating standard error of the mean. Asterisks, po0.05.
J.D. Kanady et al. / Developmental Biology 405 (2015) 33–46423.6. Foxc2þ /Cx37þ / adult mice display similar lymphatic drai-
nage patterns compared to Foxc2þ / mice
Lymphatic drainage and function have been previously eval-
uated in Foxc2þ / adult mice by using EBD lymphangiography,which revealed generalized lymphatic vessel and lymph node
hyperplasia in those animals (Kriederman et al., 2003). In our past
analysis of Cx37 / adult mice, most had EBD reﬂux in the lymph
vessels of the skin and the intercostal lymphatics, which suggested
insufﬁcient valve function and an impairment in maintaining
unidirectional lymph ﬂow (Kanady et al., 2011). Foxc2þ /Cx37 /
mice die perinatally, thus we were unable to assess adults of this
genotype. However, Foxc2þ /Cx37þ / are viable and EBD lym-
phangiography was performed on adult mice of this genotype.
Foxc2þ /Cx37þ / adult mice (3–6 months of age) exhibited si-
milar EBD drainage patterns in the ear (Fig. 10A–C), lumbar lymph
nodes (Fig. 10E–G), and thoracic duct (Fig. 10I–K) compared to
Foxc2þ / mice. Reﬂux of EBD was not found, suggesting that the
presence of a single copy of Cx37 is sufﬁcient to largely preserve
valve function in Foxc2þ /Cx37þ / mice. Since Cx43 is necessary
for lymphatic valve development (Kanady et al., 2011) and results
from ChIP-chip studies suggest that a Foxc2-NFATc1 binding site is
located near the Cx43 gene (Norrmen et al., 2009), we also eval-
uated Foxc2þ /Cx43þ / mice. No differences were found in
Foxc2þ /Cx43þ / mice (Fig. 10D,H, and L) compared to Foxc2þ /
mice.4. Discussion
4.1. Foxc2 and Cx37 involvement in bone formation
Several lymphedema-associated disorders are accompanied by
craniofacial defects (Northup et al., 2003). Lymphedema in utero
may cause these bone malformations by impairing the migration
of tissues during embryonic development (Witt et al., 1987).
However, craniofacial abnormalities can present from birth in
humans with hereditary lymphedema, even when lymphedema is
of late-childhood or adolescent onset (Fang et al., 2000). In the
animals we examined, craniofacial differences manifested both in
the presence (in Foxc2þ /Cx37 / mice) and absence (in
Foxc2þ /Cx37þ / mice) of lymphedema in utero. Thus, lymphe-
dema-dependent and lymphedema-independent effects may in-
ﬂuence bone formation in this mouse model. Indeed, both Foxc2
(Park et al., 2011) and Cx37 (Pacheco-Costa et al., 2014) are ex-
pressed by osteogenic cells, and mice with separate genetic dele-
tion of these proteins have defects in skeletogenesis and altered
structural bone characteristics (Iida et al., 1997; Pacheco-Costa
et al., 2014). At present, it is unclear whether Foxc2 and Cx37 share
molecular pathways in bone development, but the craniofacial
features that are exhibited in mice only when deﬁciencies in Foxc2
and Cx37 are combined are consistent with this idea.
4.2. Foxc2 and Cx37 in intestinal lymphangiogenesis
Remarkably, lymphangiectasia in the intestine of
Foxc2þ /Cx37 / mice was mainly localized to the proximal small
intestine, suggesting that deﬁciencies in Foxc2 and Cx37 have a
greater inﬂuence on mid-gut derived lymphatic tissues compared
to other areas. Intestinal and mesenteric lymph vessels in
Foxc2þ /Cx37 / mice were located alongside blood vessels,
evidence that basic guidance events during the establishment of
the primary lymphatic network were maintained. However, pro-
found dilation and decreased branch point density of intestinal
lymphatics indicated defects in lymphangiogenesis and vessel re-
modeling (sprouting, branching and/or anastomosis). Increased
LEC proliferation likely contributed to the enlargement of lymph
vessels, as evidenced by greater numbers of mitotic mesenteric
LECs in Cx37/ mice. This ﬁnding is consistent with studies re-
porting that Cx37 is growth suppressive (Burt et al., 2008; Fang
et al., 2011). The exact mechanism by which Cx37 controls growth
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supporting intercellular, transmembrane, and intracellular signal-
ing is necessary for growth suppression in cell culture settings
(Good et al., 2014).Fig. 9. The dermal lymphatics of Foxc2þ /Cx37/ mice at E18.5 lack valves, are smal
immunolabeling (A), (D), (G), (J), and (M) and CD31 immunolabeling (B), (E), (H), (K), an
(C), (F), (I), (L), and (O) Color composites of corresponding panels (A), (D), (G), (J), and (M
resembling a cystic lymphangioma in a Foxc2þ /Cx37 / skin sample. (P)–(U) Derma
Foxc2þ /Cx37/ mice was signiﬁcantly smaller than WT mice. Dermal lymph vessel d
vessel area density of Foxc2þ /Cx37 / mice was signiﬁcantly lower than WT and Cx37
lower than WT. (T) There were signiﬁcantly fewer dermal lymph valves in Foxc2þ /
signiﬁcant reduction in dermal lymph valves in Foxc2þ / and Cx37/ mice compared t
point density (S), or vessel tortuosity (U) between genotypes. Scale bar: (A)–(O) 200 m
presented as means, with error bars indicating standard error of the mean. Asterisks, pLacteals form part of the mucosal lymphatic network within
the small intestine, which develops secondarily to the submucosal
lymphatic network (Heuer, 1909). The lacteals of Foxc2þ /Cx37 /
mice were considerably shorter, another shortcoming of theler in caliber, and can develop structures resembling cystic lymphangiomas. Prox1
d (N) for WT, Foxc2þ / , Cx37 / , and Foxc2þ /Cx37 / dermal lymphatic vessels.
) for Prox1 (green) and (B), (E), (H), (K), (N) for CD31 (magenta). (M)–(O) Structure
l lymphatic vascular network quantitation. (P) Dermal lymph vessel diameter of
iameter of Foxc2þ / mice was also signiﬁcantly lower than WT. (Q) Dermal lymph
/ mice. Additionally, lymph vessel area density of Foxc2þ / mice was signiﬁcantly
Cx37/ mice compared to WT, Foxc2þ / , and Cx37/ mice. There was also a
o WT. There were no differences in dermal lymph vessel length density (R), branch
m. Six 10x ﬁelds were evaluated per embryo, n¼3 for each genotype. Values are
o0.05.
Fig. 10. Evans blue dye (EBD) lymphangiography of WT, Foxc2þ / , Foxc2þ /Cx37þ / , and Foxc2þ /Cx43þ / adult mice. EBD drainage patterns in the ear (A)–(D), ab-
dominal cavity (E)–(H), and thoracic cavity (I)–(L). EBD readily ﬁlled the lymphatics of ear (injection site denoted by the asterisk), the lumbar lymph nodes (E)–(H), labeled
“LN”), and thoracic duct (denoted by arrows in (I)–(L)) of WT, Foxc2þ / , Foxc2þ /Cx37þ / , and Foxc2þ /Cx43þ / mice. No obstructions or reﬂux of EBD were found in the
areas examined.
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Disruption of lacteal growth was also demonstrated in mice lack-
ing Angiopoietin-2 (Ang-2, a vascular growth factor), resulting in
abnormally short lacteals or often their absence (Gale et al., 2002).
Thus, our results place Foxc2 and Cx37 alongside Ang-2 on a brief
list of factors known to affect lacteal growth.
Clinically, intestinal lymphangiectasia can give rise to chronic
diarrhea, loss of serum proteins into the intestinal lumen (protein-
losing enteropathy), and impaired absorption of fats and fat-so-
luble vitamins (Vignes and Bellanger, 2008). Coupled with defec-
tive lacteal development, intestinal loss of serum proteins and
nutrient malabsorption during critical postnatal periods may have
contributed to postnatal death in Foxc2þ /Cx37 / mice.4.3. Lymph–blood mixing
The presence of blood in discrete regions of the dermal, in-
testinal, and pericardial lymphatics late in embryonic develop-
ment might be explained by inappropriate anastomoses between
the lymphatic and blood vasculature in Foxc2þ /Cx37 / mice,
but we did not ﬁnd morphological evidence for this phenomenon.
However, a more exhaustive histological analysis may be required
to rule out this possibility. Alternatively, lymphovenous valve de-
fects may be a factor in lymph–blood mixing. Incidentally, whileaccumulation of blood within lymph vessels may be partly re-
sponsible for their dilation in each of these regions, enlargement
of vessels in areas devoid of lymph-–blood mixing argues
that disturbed lymphangiogenesis was a major cause of
lymphangiectasia.
4.4. Foxc2, Cx37, and Cx43 in lymphatic valve development
Based on data showing that Cx45 in cardiac endothelium was
necessary for activation of NFATc1 with epithelial-mesenchymal
transformation during cardiac valve morphogenesis, it was sug-
gested that connexins were involved in calcineurin/NFATc1 sig-
naling (Kumai et al., 2000). Oscillatory shear stress experiments on
LECs in culture have shown that Cx37 is also required for co-
ordinated activation of NFATc1 (Sabine et al., 2012). Foxc2 binding
sites within the genome have been identiﬁed in proximity to
predicted NFATc1 sites, and luciferase reporter assays using frag-
ments from some of those identiﬁed regions showed synergistic
activation in the presence of both Foxc2 and NFATc1 (Norrmen
et al., 2009). Additionally, lymphatic Cx37 gene expression is
greatly reduced in the absence of Foxc2 and a partial genetic in-
teraction between Foxc2 and Cx37 was suggested by increased
immature valves in Foxc2þ /Cx37þ / mice (Kanady et al., 2011;
Sabine et al., 2012). These ﬁndings have coalesced into a proposed
model whereby mechanotransduction, Prox1, and Foxc2 are
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lymphatic valve development (Sabine et al., 2012).
Our data concerning the absence of intraluminal valves in the
lymphatic collectors of the skin and mesentery of
Foxc2þ /Cx37/ mice at E18.5 are consistent with the model
above. Connexin-based calcium signaling has been demonstrated
to occur via intercellular diffusion of Ca2þ or inositol trispho-
sphate through gap junctions (Boitano et al., 1992; Giaume and
Venance, 1998) or by purinergic nucleotide-based paracrine me-
chanisms via hemichannels (Ponsaerts et al., 2010). Thus, one
possible scenario in Foxc2þ /Cx37 / mice is that the loss of Cx37
represents a reduced capacity for connexin-mediated calcium
signaling in response to mechanical events, leading to decreased
activation of calcineurin and lower levels of activated NFATc1.
Coupled with a prima facie reduction in the levels of Foxc2 in
Foxc2þ / mice, a subsequent decrease in Foxc2-NFATc1 co-
operative regulation of gene expression might be expected in
Foxc2þ /Cx37/ mice.
The phenotype of Foxc2þ /Cx37 / mice affords new insights
into the relation of these two proteins to lymphatic valve devel-
opment. Since Foxc2þ / and Cx37/ mice each have approxi-
mately a 50% reduction in the number of developing lymphatic
valves in the skin at E18.5, the complete loss of valves in
Foxc2þ /Cx37/ embryos points to a synergistic effect of Foxc2
and Cx37 on valve formation. Moreover, there was no evidence of
localized upregulation of Prox1 (demarcating valve-forming areas)
during lymph vessel remodeling in Foxc2þ /Cx37/ mice, in-
dicating that valve formation failed to initiate or was arrested at
very early stages. On the other hand, mice lacking just Cx37 do
show localized, circumferential upregulation of Prox1 during early
lymphatic valve genesis, but often have defective valve maturation
(Kanady et al., 2011; Sabine et al., 2012). Therefore, in the absence
of Cx37, having half the genetic complement of Foxc2 is not suf-
ﬁcient to initiate the valve formation program. These data suggest
that the function of Foxc2 (or that of a protein that it functionally
interacts with, such as NFATc1) depends on Cx37 expression dur-
ing lymphatic valvulogenesis.
4.5. Foxc2 and Cx37 in dermal lymphangiogenesis
The morphological changes in the dermal lymphatic network of
Foxc2þ /Cx37/ mice (overall reduction in vessel caliber and
lower density of coverage) run counter to those of the collecting
vessels of the mesentery and intestine (increased vessel caliber
and higher area density). Cx37 is expressed to a lesser extent in
dermal lymphatic capillaries (Kanady et al., 2011) compared to
lymphatic collecting vessels, and this difference may reﬂect a
functionally distinct role of Cx37 in certain vessel types. However,
consistent with vessel enlargement seen in the mesentery and
intestine, portions of the dermal lymphatic network were also
enlarged and structures resembling lymphangiomas developed in
some of these mice.
The basis of the differing growth/remodeling effects of Foxc2
and Cx37 on speciﬁc levels of the lymphatic vascular hierarchy is
unclear. One possible explanation may be related to LEC versus
non-LEC connexin expression and function. Cx37 is expressed by
macrophages where it is involved in modulating ATP-dependent
adhesion (Wong et al., 2006) and these cells play a role in deﬁning
dermal lymphatic vascular caliber by limiting LEC proliferation
(Gordon et al., 2010). Therefore, the loss of Cx37 in macrophages
may be partly responsible for the changes in lymphatic vascular
caliber seen in Foxc2þ /Cx37 / mice. In addition, recent lineage
tracing experiments have provided evidence for a non-venous
origin of portions of the dermal (Martinez-Corral et al., 2015)
and mesenteric (Stanczuk et al., 2015) lymphatic vasculature in
mice, through a process of lymphvasculogenesis. Hence, anotherpossible explanation for lymphatic-bed speciﬁc changes in
Foxc2þ /Cx37 / mice is differing functions for Foxc2 and Cx37 in
lymphvasculogenesis versus lymphangiogenesis.4.6. Relating Foxc2þ /Cx37 / mice and hereditary lymphatic dis-
orders in humans
Certain phenotypic abnormalities in Foxc2þ /Cx37 / mice
can also be seen in a number of lymphedema-associated and
hereditary lymphatic disorders in humans. For example, von
Recklinghausen, Turner, Noonan, Klippel-Trenaunay, and Henne-
kam syndromes are all associated with intestinal lymphangiectasia
(Vignes and Bellanger, 2008). Biopsy samples from the duodenum
of patients with intestinal lymphangiectasia showed more than a
ﬁve-fold reduction in mRNA expression levels of FOXC2 compared
to control (Hokari et al., 2008). While CX37 mRNA expression was
not assessed in those patients, we would expect similar reductions
given previous data correlating Foxc2 and Cx37 expression levels
in mice (Kanady et al., 2011; Sabine et al., 2012). Thus, examining
these proteins together may beneﬁt future studies attempting to
identify the etiology of lymphatic disorders (particularly involving
lymphangiectasia) in humans.
4.7. Summary
This study shows that both Foxc2 and Cx37 are necessary for
lymphangiogenesis to progress correctly. A number of new lym-
phatic defects manifest when hemizygous deletion of Foxc2 is
combined with complete ablation of Cx37 (compared to those
resulting from their individual loss). Establishment of the primary
lymphatic plexus occurs in Foxc2þ /Cx37 / mice, but its re-
modeling into a functional vascular network replete with lym-
phatic valves is severely impaired. Foxc2þ /Cx37 / mice also
have dysmorphic cranial development, indicating that Foxc2 and
Cx37 may have shared domains of control in bone development as
well. The abnormalities that occur in Foxc2þ /Cx37/ mice are
similar to the spectrum of symptoms seen in some lymphedema-
associated disorders.Acknowledgements
The authors would like to thank José Ek-Vitorín for numerous
enlightening discussions regarding this work and comments on
the manuscript. This work was supported by National Heart, Lung,
and Blood Institute, USA Grants R01-HL64232 (to A.M. Simon) and
T32-HL007249 (to J.M. Burt, supporting J.D. Kanady).Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at 10.1016/j.ydbio.2015.06.004.References
Alexander, J.S., Ganta, V.C., Jordan, P.A., Witte, M.H., 2010. Gastrointestinal lym-
phatics in health and disease. Pathophysiology 17, 315–335.
Arganda-Carreras, I., Fernández-González, R., Muñoz-Barrutia, A., Ortiz-De-So-
lorzano, C., 2010. 3D reconstruction of histological sections: application to
mammary gland tissue. Microsc. Res. Tech. 73, 1019–1029.
Boitano, S., Dirksen, E.R., Sanderson, M.J., 1992. Intercellular propagation of calcium
waves mediated by inositol trisphosphate. Science 258, 292–295.
Brice, G., Ostergaard, P., Jeffery, S., Gordon, K., Mortimer, P.S., Mansour, S., 2013. A
novel mutation in GJA1 causing oculodentodigital syndrome and primary
J.D. Kanady et al. / Developmental Biology 405 (2015) 33–4646lymphoedema in a three generation family. Clin. Genet. 84, 378–381.
Burt, J.M., Nelson, T.K., Simon, A.M., Fang, J.S., 2008. Connexin 37 profoundly slows
cell cycle progression in rat insulinoma cells. Am. J. Physiol. Cell Physiol. 295,
C1103–C1112.
Fang, J., Dagenais, S.L., Erickson, R.P., Arlt, M.F., Glynn, M.W., Gorski, J.L., Seaver, L.H.,
Glover, T.W., 2000. Mutations in FOXC2 (MFH-1), a forkhead family transcrip-
tion factor, are responsible for the hereditary lymphedema-distichiasis syn-
drome. Am. J. Hum. Genet. 67, 1382–1388.
Fang, J.S., Angelov, S.N., Simon, A.M., Burt, J.M., 2011. Cx37 deletion enhances vas-
cular growth and facilitates ischemic limb recovery. Am. J. Physiol. Heart Circ.
Physiol. 301, H1872–H1881.
Ferrell, R.E., Baty, C.J., Kimak, M.A., Karlsson, J.M., Lawrence, E.C., Franke-Snyder, M.,
Meriney, S.D., Feingold, E., Finegold, D.N., 2010. GJC2 missense mutations cause
human lymphedema. Am. J. Hum. Genet. 86, 943–948.
Gale, N.W., Thurston, G., Hackett, S.F., Renard, R., Wang, Q., McClain, J., Martin, C.,
Witte, C., Witte, M.H., Jackson, D., Suri, C., Campochiaro, P.A., Wiegand, S.J.,
Yancopoulos, G.D., 2002. Angiopoietin-2 is required for postnatal angiogenesis
and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.
Dev. Cell 3, 411–423.
Giaume, C., Venance, L., 1998. Intercellular calcium signaling and gap junctional
communication in astrocytes. Glia 24, 50–64.
Good, M.E., Ek-Vitorín, J.F., Burt, J.M., 2014. Structural determinants and pro-
liferative consequences of connexin 37 hemichannel function in insulinoma
cells. J. Biol. Chem. 289, 30379–30386.
Gordon, E.J., Rao, S., Pollard, J.W., Nutt, S.L., Lang, R.A., Harvey, N.L., 2010. Macro-
phages deﬁne dermal lymphatic vessel calibre during development by reg-
ulating lymphatic endothelial cell proliferation. Development 137, 3899–3910.
Hendzel, M.J., Wei, Y., Mancini, M.A., Van Hooser, A., Ranalli, T., Brinkley, B.R., Ba-
zett-Jones, D.P., Allis, C.D., 1997. Mitosis-speciﬁc phosphorylation of histone H3
initiates primarily within pericentromeric heterochromatin during G2 and
spreads in an ordered fashion coincident with mitotic chromosome con-
densation. Chromosoma 106, 348–360.
Heuer, G., 1909. The development of the lymphatics in the small intestine of the
pig. Am. J. Anat. 9, 93–118.
Hokari, R., Kitagawa, N., Watanabe, C., Komoto, S., Kurihara, C., Okada, Y., Kawa-
guchi, A., Nagao, S., Hibi, T., Miura, S., 2008. Changes in regulatory molecules for
lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss. J.
Gastroenterol. Hepatol. 23, e88–e95.
Iida, K., Koseki, H., Kakinuma, H., Kato, N., Mizutani-Koseki, Y., Ohuchi, H., Yoshioka,
H., Noji, S., Kawamura, K., Kataoka, Y., Ueno, F., Taniguchi, M., Yoshida, N., Su-
giyama, T., Miura, N., 1997. Essential roles of the winged helix transcription
factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124,
4627–4638.
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V.W., Fang, G.H., Dumont,
D., Breitman, M., Alitalo, K., 1995. Expression of the fms-like tyrosine kinase
4 gene becomes restricted to lymphatic endothelium during development.
Proc. Natl. Acad. Sci. USA 92, 3566–3570.
Kanady, J.D., Dellinger, M.T., Munger, S.J., Witte, M.H., Simon, A.M., 2011. Con-
nexin37 and Connexin43 deﬁciencies in mice disrupt lymphatic valve devel-
opment and result in lymphatic disorders including lymphedema and chy-
lothorax. Dev. Biol. 354, 253–266.
Karkkainen, M.J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T.V., Jeltsch, M.,
Jackson, D.G., Talikka, M., Rauvala, H., Betsholtz, C., Alitalo, K., 2004. Vascular
endothelial growth factor C is required for sprouting of the ﬁrst lymphatic
vessels from embryonic veins. Nat. Immunol. 5, 74–80.
Kim, K.E., Sung, H.-K., Koh, G.Y., 2007. Lymphatic development in mouse small
intestine. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 236, 2020–2025.
Koltowska, K., Betterman, K.L., Harvey, N.L., Hogan, B.M., 2013. Getting out and
about: the emergence and morphogenesis of the vertebrate lymphatic vascu-
lature. Development 140, 1857–1870.
Kriederman, B.M., Myloyde, T.L., Witte, M.H., Dagenais, S.L., Witte, C.L., Rennels, M.,
Bernas, M.J., Lynch, M.T., Erickson, R.P., Caulder, M.S., Miura, N., Jackson, D.,
Brooks, B.P., Glover, T.W., 2003. FOXC2 haploinsufﬁcient mice are a model for
human autosomal dominant lymphedema-distichiasis syndrome. Hum. Mol.
Genet. 12, 1179–1185.
Kumai, M., Nishii, K., Nakamura, K., Takeda, N., Suzuki, M., Shibata, Y., 2000. Loss of
connexin45 causes a cushion defect in early cardiogenesis. Development 127,
3501–3512.
Li, D.W., Yang, Q., Chen, J.T., Zhou, H., Liu, R.M., Huang, X.T., 2005. Dynamic dis-
tribution of Ser-10 phosphorylated histone H3 in cytoplasm of MCF-7 and CHO
cells during mitosis. Cell Res. 15, 120–126.
Longair, M.H., Baker, D.A., Armstrong, J.D., 2011. Simple neurite tracer: open source
software for reconstruction, visualization and analysis of neuronal processes.
Bioinformatics 27, 2453–2454.Martinez-Corral, I., Ulvmar, M., Stanczuk, L., Tatin, F., Kizhatil, K., John, S.W., Alitalo,
K., Ortega, S., Makinen, T., 2015. Non-venous origin of dermal lymphatic vas-
culature. Circ. Res. 116, 306170.
Munger, S.J., Kanady, J.D., Simon, A.M., 2013. Absence of venous valves in mice
lacking Connexin37. Dev. Biol. 373, 338–348.
Norrmen, C., Ivanov, K.I., Cheng, J., Zangger, N., Delorenzi, M., Jaquet, M., Miura, N.,
Puolakkainen, P., Horsley, V., Hu, J., Augustin, H.G., Yla-Herttuala, S., Alitalo, K.,
Petrova, T.V., 2009. FOXC2 controls formation and maturation of
lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185,
439–457.
Northup, K.A., Witte, M.H., Witte, C.L., 2003. Syndromic classiﬁcation of hereditary
lymphedema. Lymphology 36, 162–189.
Pacheco-Costa, R., Hassan, I., Reginato, R.D., Davis, H.M., Bruzzaniti, A., Allen, M.R.,
Plotkin, L.I., 2014. High bone mass in mice lacking Cx37 due to defective os-
teoclast differentiation. J. Biol. Chem. M113, 529735.
Park, S.J., Gadi, J., Cho, K.-W., Kim, K.J., Kim, S.H., Jung, H.-S., Lim, S.-K., 2011. The
forkhead transcription factor Foxc2 promotes osteoblastogenesis via up-reg-
ulation of integrin β1 expression. Bone 49, 428–438.
Petrova, T.V., Karpanen, T., Norrmén, C., Mellor, R., Tamakoshi, T., Finegold, D.,
Ferrell, R., Kerjaschki, D., Mortimer, P., Ylä-Herttuala, S., Miura, N., Alitalo, K.,
2004. Defective valves and abnormal mural cell recruitment underlie lymphatic
vascular failure in lymphedema distichiasis. Nat. Med. 10, 974–981.
Ponsaerts, R., de Vuyst, E., Retamal, M., D’hondt, C., Vermeire, D., Wang, N., De
Smedt, H., Zimmermann, P., Himpens, B., Vereecke, J., Leybaert, L., Bultynck, G.,
2010. Intramolecular loop/tail interactions are essential for connexin 43-
hemichannel activity. FASEB J. 24, 4378–4395.
Reaume, A.G., de Sousa, P.A., Kulkarni, S., Langille, B.L., Zhu, D., Davies, T.C., Juneja, S.
C., Kidder, G.M., Rossant, J., 1995. Cardiac malformation in neonatal mice
lacking connexin43. Science 267, 1831–1834.
Sabine, A., Agalarov, Y., Maby-El Hajjami, H., Jaquet, M., Hägerling, R., Pollmann, C.,
Bebber, D., Pfenniger, A., Miura, N., Dormond, O., Calmes, J.-M., Adams, R.H.,
Mäkinen, T., Kiefer, F., Kwak, B.R., Petrova, T.V., 2012. Mechanotransduction,
PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during
lymphatic-valve formation. Dev. Cell (22), 430–445.
Shimoda, H., Bernas, M.J., Witte, M.H., 2011. Dysmorphogenesis of lymph nodes in
Foxc2 haploinsufﬁcient mice. Histochem. Cell Biol. 135, 603–613.
Sholto-Douglas-Vernon, C., Bell, R., Brice, G., Mansour, S., Sarfarazi, M., Child, A.H.,
Smith, A., Mellor, R., Burnand, K., Mortimer, P., Jeffery, S., 2005. Lymphoedema-
distichiasis and FOXC2: unreported mutations, de novo mutation estimate, fa-
milies without coding mutations. Hum. Genet. 117, 238–242.
Simon, A.M., Chen, H., Jackson, C.L., 2006. Cx37 and Cx43 localize to zona pellucida
in mouse ovarian follicles. Cell Commun. Adhes. 13, 61–77.
Simon, A.M., Goodenough, D.A., Li, E., Paul, D.L., 1997. Female infertility in mice
lacking connexin 37. Nature 385, 525–529.
Stanczuk, L., Martinez-Corral, I., Ulvmar, M.H., Zhang, Y., Laviña, B., Fruttiger, M.,
Adams, R.H., Saur, D., Betsholtz, C., Ortega, S., Alitalo, K., Graupera, M., Mäkinen,
T., 2015. cKit lineage hemogenic endothelium-derived cells contribute to me-
senteric lymphatic vessels. Cell Rep. 10, 1708–1721.
Tapia, C., Kutzner, H., Mentzel, T., Savic, S., Baumhoer, D., Glatz, K., 2006. Two mi-
tosis-speciﬁc antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid
and precise determination of mitotic activity. Am. J. Surg. Pathol. 30, 83–89.
Vignes, S., Bellanger, J., 2008. Primary intestinal lymphangiectasia (Waldmann’s
disease). Orphanet J. Rare Dis. 3, 5.
Wang, Y., Oliver, G., 2010. Current views on the function of the lymphatic vascu-
lature in health and disease. Genes Dev. 24, 2115–2126.
Winnier, G.E., Hargett, L., Hogan, B.L., 1997. The winged helix transcription factor
MFH1 is required for proliferation and patterning of paraxial mesoderm in the
mouse embryo. Genes Dev. 11, 926–940.
Witt, D.R., Hoyme, H.E., Zonana, J., Manchester, D.K., Fryns, J.P., Stevenson, J.G.,
Curry, C.J., Hall, J.G., 1987. Lymphedema in Noonan syndrome: clues to pa-
thogenesis and prenatal diagnosis and review of the literature. Am. J. Med.
Genet. 27, 841–856.
Witte, M.H., Erickson, R.P., Khalil, M., Dellinger, M., Bernas, M., Grogan, T., Nitta, H.,
Feng, J., Duggan, D., Witte, C.L., 2009. Lymphedema-distichiasis syndrome
without FOXC2 mutation: evidence for chromosome 16 duplication upstream
of FOXC2. Lymphology 42, 152–160.
Wong, C.W., Christen, T., Roth, I., Chadjichristos, C.E., Derouette, J.-P., Foglia, B.F.,
Chanson, M., Goodenough, D.A., Kwak, B.R., 2006. Connexin37 protects against
atherosclerosis by regulating monocyte adhesion. Nat. Med. 12, 950–954.
Zudaire, E., Gambardella, L., Kurcz, C., Vermeren, S., 2011. A computational tool for
quantitative analysis of vascular networks. PLoS One 6.
